Letermovir-based Dual Therapy for Treatment of Cytomegalovirus Infections

Clinical trial NCT06334497 · RECRUITING

Trial details

NCT number: NCT06334497
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Cytomegalovirus Infection

Start date: 2024-08-14
Primary completion: 2027-09-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.